Tuberous Sclerosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
Condition:   Facial Angiofibroma Interventions:   Drug: Rapamycin;   Drug: Calcitriol;   Drug: Rapamycin-calcitriol combination Sponsor:   National Taiwan University Hospital Completed - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2017 Category: Research Source Type: clinical trials